A phase II, open-label, multicenter trial to investigate the clinical activity and safety of avelumab (MSB0010718C) in patients with metastatic Merkel cell carcinoma Meeting Abstract


Authors: Kaufman, H.; Hamid, O.; D'Angelo, S. P.; Yuan, G. J.; Chin, K. M.; Bhatia, S.; Cuillerot, J. M.; Nghiem, P.
Abstract Title: A phase II, open-label, multicenter trial to investigate the clinical activity and safety of avelumab (MSB0010718C) in patients with metastatic Merkel cell carcinoma
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036904884
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.tps9086
Notes: Meeting Abstract: TPS9086 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sandra Pierina D'Angelo
    252 D'Angelo